FDA warning on certain eye drops and saline (updated 2/1/24)

PROSE Patient, Alyssa Carfi, is Inspired to Support Others Through the Brave Minds Project

Alyssa Carfi had a brainstem cavernoma, a condition where blood vessels are clustered together, and in her case, lodged deep in her brainstem. The condition caused bleeding in her brainstem three times: when she was 12, 15, and 18 years old.  On the third occurrence, her doctors knew they had to try to remove it before it caused further damage.  Just three days after graduating high school, Alyssa went in for surgery. Alyssa, standing, with Dr. Michelle Lee, and a PROSE patient who received financial support from Brave Minds. Based on their location, brainstem cavernomas can cause significant surgical challenges. Alyssa’s cavernoma bled near her 6th and 7th cranial nerves, which affected her right eye and smile. Following her surgery, Alyssa’s right eye rotated in toward her nose, and she had facial paralysis, affecting her eyelid and ability to open and close her right eye. She underwent strabismus surgery to center her eye, and had weights put into her upper lid to help with the closure, but she was still unable to blink, leaving her right eyelid permanently open, day and night. This left her eye exposed to debris, sun, and wind, causing irritation and dryness, and risk of ongoing damage and pain. For two years, Alyssa used eye drops and serums constantly. She would go through a large box of drops in days. She and her family saw more than 10 doctors at various hospitals and in various states, looking for a better way to live. She [...]

2024-04-04T13:53:44-04:00January 29, 2021|PROSE, Blog Posts|

BostonSight Grows PROSE™ Provider Network

Expanding Access to Life Changing Eye Care That Restores Vision in People with Corneal Disease Needham, Mass. –September 15, 2020 – BostonSight®, a nonprofit eye healthcare organization and research center dedicated to saving sight and improving quality of life for patients, announced today they have added three PROSE™ Provider sites and four PROSE Clinical Fellows to the BostonSight PROSE Network. With this addition, the BostonSight PROSE Provider Network now includes 18 sites in four countries. BostonSight PROSE is a custom medical treatment model that saves sight in individuals with ocular surface disease. During treatment, doctors customize prosthetic devices from gas-permeable polymers for each patient’s condition and unique eye shape. For many people, PROSE treatment is their only option to restore visual function and end suffering from critical and devastating eye issues resulting from complications with dry eye, keratoconus, ocular GVHD, Sjögren’s Syndrome, Stevens Johnson Syndrome, corneal damage or injury, and other corneal diseases. PROSE treatment teams include cornea specialist ophthalmologists and optometrists who have completed an intensive BostonSight PROSE Clinical Fellowship. “Our mission at BostonSight is to expand our network of PROSE providers, elevate the standard of patient care, and improve quality of life for those who are suffering from corneal irregularities or ocular surface disease,” said Sara Yost, BostonSight President and CEO. “We are excited to welcome our newest PROSE Network Clinics and Fellows to provide broader access to this life-changing treatment. The new Fellows are highly regarded and experienced in the treatment of ocular surface disease and will continue to provide the expert level of care [...]

2024-04-04T12:36:26-04:00September 15, 2020|Press Release|
Go to Top